De Novo Mutations in SLC35A2 Encoding a UDP-Galactose Transporter Cause Early-Onset Epileptic Encephalopathy
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Early-onset epileptic encephalopathies (EOEE) are severe neurological disorders characterized by frequent seizures accompanied by developmental regression or retardation. Whole-exome sequencing of 12 patients together with five pairs of parents and subsequent Sanger sequencing in additional 328 EOEE patients identified two de novo frameshift and one missense mutations in SLC35A2 at Xp11.23, respectively. The three patients are all females. X-inactivation analysis of blood leukocyte DNA and mRNA analysis using lymphoblastoid cells derived from two patients with a frameshift mutation indicated that only the wild-type SLC35A2 allele was expressed in these cell types, at least in part likely as a consequence of skewed X-inactivation. SLC35A2 encodes a UDP-galactose transporter (UGT), which selectively supplies UDP-galactose from the cytosol to the Golgi lumen. Transient expression experiments revealed that the missense mutant protein was correctly localized in the Golgi apparatus. In contrast, the two frameshift mutant proteins were not properly expressed, suggesting that their function is severely impaired. Defects in the UGT can cause congenital disorders of glycosylation. Of note, no abnormalities of glycosylation were observed in three serum glycoproteins, which is consistent with favorably skewed X-inactivation. We hypothesize that a substantial number of neurons might express the mutant SLC35A2 allele and suffer from defective galactosylation, resulting in EOEE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292 · cited 2×
“Recently, several causative genes have been reported in patients both with well-recognized and unclassified EOEE syndromes: ARX (MIM #300382), CDKL5 (MIM #300203), STXBP1 (MIM #602926), SLC25A22 (MIM #609302), SCN1A (MIM #182389), KCNQ2 (MIM #602235), and KCNT1 (MIM #608167) [Barcia et al., 2012; Claes et al., 2001; K…”
BackgroundBarcia, G., Fleming, M. R., Deligniere, A., Gazula, V.-R., Brown, M. R., Langouet, M., Chen, H., Kronengold, J., Abhyankar, A., Cilio, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.2441 · Cited by 525 · cited 2×
“Recently, several causative genes have been reported in patients both with well-recognized and unclassified EOEE syndromes: ARX (MIM #300382), CDKL5 (MIM #300203), STXBP1 (MIM #602926), SLC25A22 (MIM #609302), SCN1A (MIM #182389), KCNQ2 (MIM #602235), and KCNT1 (MIM #608167) [Barcia et al., 2012; Claes et al., 2001; K…”
BackgroundKCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R. F., Deprez, L., Smets, K., Hristova, D., Yordanova, I., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22644 · Cited by 514
Saitsu, H., Nishimura, T., Muramatsu, K., Kodera, H., Kumada, S., Sugai, K., Kasai-Yoshida, E., Sawaura, N., Nishida, H., Hoshino, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2562 · Cited by 474 · cited 1×
“Exome data processing, variant calling, and variant annotation were performed as previously described [DePristo et al., 2011; Saitsu et al., 2013; Wang et al., 2010].”
MethodSelf-citation
Cited by
De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies
Appenzeller, S., Balling, R., Barisic, N., Baulac, S., Caglayan, H., Craiu, D., De Jonghe, P., Depienne, C., Dimova, P., Djémié, T., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.08.013 · Cited by 439
The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms
Meech, R., Hu, D. G., McKinnon, R. A., Mubarokah, S. N., Haines, A. Z., Nair, P. C., Rowland, A., & Mackenzie, P. I. (2019) · Physiological Reviews · doi:10.1152/physrev.00058.2017 · Cited by 368
Jaeken, J., & Péanne, R. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0050-6 · Cited by 170
“There is a partial treatment for PIGM-CDG (oral butyrate controls seizures), SLC35C1-CDG (oral fucose controls infections), DOLK-CDG (heart transplantation), PGM1-CDG (galactose improves liver function and endocrine abnormalities, and reduces hypoglycemic episodes; Morava 2014), SLC35A2-CDG and SLC39A8CDG (galactose i…”
InfluentialHarvey, D. J. (2018) · Mass Spectrometry Reviews · doi:10.1002/mas.21530 · Cited by 61
Brand, B. A., Blesson, A. E., & Smith-Hicks, C. L. (2021) · Brain Sciences · doi:10.3390/brainsci11070904 · Cited by 39
Metadata
- Authors
- Kodera, H., Nakamura, K., Osaka, H., Maegaki, Y., Haginoya, K., Mizumoto, S., Kato, M., Okamoto, N., Iai, M., Kondo, Y., Nishiyama, K., Tsurusaki, Y., Nakashima, M., Miyake, N., Hayasaka, K., Sugahara, K., Yuasa, I., Wada, Y., Matsumoto, N., & Saitsu, H.
- Venue
- Human Mutation
- Publisher
- Hindawi Limited
- Published
- 2013-10-15
- Volume
- 34
- Issue
- 12
- Pages
- 1708-1714
- ISSN
- 1059-7794 (ISSN-L)
- OpenAlex
- W2165166622
- Cited by
- 110
- References
- 4
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: De Novo Mutations in SLC35A2 Encoding a UDP-Galactose Transporter Cause Early-Onset Epileptic Encephalopathy. https://app.cochat.ai/papers/10.1002/humu.22446
- The paper
- Kodera, H., Nakamura, K., Osaka, H., Maegaki, Y., Haginoya, K., Mizumoto, S., Kato, M., Okamoto, N., Iai, M., Kondo, Y., Nishiyama, K., Tsurusaki, Y., Nakashima, M., Miyake, N., Hayasaka, K., Sugahara, K., Yuasa, I., Wada, Y., Matsumoto, N., & Saitsu, H. (2013). De Novo Mutations in SLC35A2 Encoding a UDP-Galactose Transporter Cause Early-Onset Epileptic Encephalopathy. Human Mutation. https://doi.org/10.1002/humu.22446
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.